MSN Laboratories require Group Leader - R&D
MSN Group is one of the fastest growing manufacturers of Active Pharmaceutical Ingredients (APIs) and Finished dosages in India. Established in the year 2003, MSN Group comprises of four API manufacturing plants, one finished dosage facility and a dedicated Technology development center. Our plants are ISO 9001-2000 certified, WHO: GMP, EU:GMP and USFDA approved. Our manufacturing units are designed to confirms to the principles of Quality, Safety and sound Environment
Cadila Pharmaceuticals Ltd. (CPL) Is one of India’s most reputed, research-based, techno-savvy pharmaceutical companies with a focus in the area of Formulations & APIs and having its Corporate Office at Bhat, Ahmedabad and State-of-art manufacturing facilities at Dholka, Ankleshwar, Kadi and Jammu accredited with USFDA, MHRA, TGA, MCA, MCC & WHO certifications.
Shreya Group has interests in both pharmaceutical and biopharmaceutical products in key therapeutic segments. Currently, Shreya operates in Russia, CIS, India, South East Asia and African countries. The Group turnover for the year 2006 was US $ 581 million including US $ 85 million in India.
Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.
